CBS News | Feb 18, 2018
A test to help diagnose traumatic brain injury, produced by Banyan Biomarkers, has received approval from the Food and Drug Administration. The test works to detect two proteins that leak into the blood stream following a head injury, and is capable of doing so within 12 hours of when the injury took place. Patients who test positive would be referred for CT scans to confirm results and determine the course of action. Banyan Biomarker’s innovative test “sets the stage for a more modernized standard of care for testing of suspected cases,” as Gottlieb stated within the article.